TherOx Inc. announced it has received U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval for a confirmatory safety study of a second-generation supersaturated oxygen (SSO2) therapy system. The system helps reduce infarct size after an acute myocardial infarction (AMI). This 100-patient study is being conducted to support a pre-market approval submission to the FDA.

PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a randomized trial studying a new heart valve to treat aortic valve disorders. Harrisburg Hospital is the only trial site in Pennsylvania. This study represents the next wave of research with aortic valves that conform to the patient's anatomy.

Complex Interventional Cardiovascular Therapy (CICT)

Heart Team Mitral Valve Meeting

TCT Russia - Moscow Interventional Course on Endovascular Therapies

Society of Cardiovascular Computed Tomography (SCCT)

Global Summit on Innovations in Interventions (GI2)

Charing Cross Interventional Symposium

National Interventional Council - Cardiological Society of India

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now